Hong Kong stocks surged | CSPC Pharmaceutical Group Limited (01276.HK) rose nearly 7% in early trading, and the listing application for Rivaroxaban tablets was accepted by the European Medicines Agency.

According to the Securities Times app, Hengrui Medicine (01276.HK) rose nearly 7% in the morning session. As of the time of publication, it has increased by 4.64% to 57.5 Hong Kong dollars, with a turnover of 1.46 billion Hong Kong dollars.